Nano Olger, Ivanov Stanislav, Kapoor Tarun
Department of Hematology and Oncology, Memorial Healthcare System, Hollywood, FL 33021, USA.
Department of Hematology and Oncology, Memorial Cancer Institute, Pembroke Pines, FL 33026, USA.
J Med Cases. 2023 May;14(5):162-168. doi: 10.14740/jmc4073. Epub 2023 May 31.
Vanishing bile duct syndrome (VBDS) is an acquired syndrome characterized by clinical and laboratory signs of cholestasis with pathologic findings of interlobular bile duct paucity in liver biopsy specimens. VBDS can result from a variety of conditions including infections, autoimmune diseases, adverse drug reactions, and neoplastic processes. Hodgkin lymphoma (HL) is a rare cause of VBDS. The mechanism by which HL leads to VBDS remains unknown. Development of VBDS in patients with HL portends an extremely poor prognosis due to the risk of progression to fulminant hepatic failure. Treatment of the underlying lymphoma has been demonstrated to offer increased probability of recovery from VBDS. The decision to treat and choice of treatment of the underlying lymphoma is often complicated by the hepatic dysfunction characteristic of VBDS. We present the case of a patient who presented with dyspnea and jaundice in the context of recurrent HL and VBDS. We additionally review the literature on HL complicated by VBDS with specific focus on treatment paradigms for management of these patients.
消失胆管综合征(VBDS)是一种获得性综合征,其特征为胆汁淤积的临床和实验室表现,以及肝活检标本中小叶间胆管稀少的病理表现。VBDS可由多种情况引起,包括感染、自身免疫性疾病、药物不良反应和肿瘤性病变。霍奇金淋巴瘤(HL)是VBDS的罕见病因。HL导致VBDS的机制尚不清楚。HL患者发生VBDS预示着预后极差,因为有进展为暴发性肝衰竭的风险。已证明治疗潜在的淋巴瘤可提高从VBDS恢复的可能性。治疗潜在淋巴瘤的决策和治疗选择常常因VBDS特有的肝功能障碍而变得复杂。我们报告一例在复发性HL和VBDS背景下出现呼吸困难和黄疸的患者。我们还回顾了关于HL合并VBDS的文献,特别关注这些患者的治疗模式。